Osteoporosis
From the Journals
Osteoporosis linked to increased risk of hearing loss
Moderate to severe hearing loss was independently associated with osteoporosis, vertebral fracture in the large, longitudinal Nurses’ Health Study...
From the Journals
Any bone break increases risk for subsequent fracture in older women
Although most guidelines warn of subsequent fracture risk after hip and spine fractures, the increased risk is seen in a multitude of other bone...
Guidelines
Don’t screen for vitamin D in general population, says USPSTF
There is insufficient evidence that screening for vitamin D deficiency among the asymptomatic general population is of any benefit, concludes an...
Guidelines
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
Conference Coverage
Romosozumab may not increase cardiovascular risk after all
Could a cardioprotective effect of bisphosphonates in a pivotal clinical trial of romosozumab explain why the biologic was given a black-box...
From the Journals
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fractures
"A 3% increase in the relative risk of osteoporosis and MOF was observed per doubling of the TCS dose."
From the Journals
Temper enthusiasm for long-term treatment with bisphosphonates?
A real-world study of nearly 30,000 women shows no benefit, in terms of hip fracture risk, between taking oral bisphosphonates for 10 years vs. 5...
From the Journals
Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients
The risk of fracture in patients taking both drugs rose beyond what was seen in those taking either drug alone in this retrospective, population-...
Clinical Review
2020 Update on bone health
A bone health expert considers recent evidence on osteosarcopenia as a risk factor, consequences of delayed denosumab dosing, bisphosphonates and...
Conference Coverage
Denosumab favored over alendronate for BMD protection in glucocorticoid-induced osteoporosis
Denosumab “may be considered as an alternative first-line therapy in higher-risk patients and in those who are contraindicated for the oral...
Conference Coverage
Osteoporosis underdiagnosed in older men with fracture
Even men at high risk for the disease are overlooked for screening as osteoporosis has been thought of as a disease of White women.